Viewing StudyNCT00250926



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00250926
Status: COMPLETED
Last Update Posted: 2016-04-08
First Post: 2005-11-08

Brief Title: Study of the Combination of Bortezomib Dexamethasone and Rituximab in Patients With Waldenstroms Macroglobulinemia
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Waldenstroms Macroglobulinemia
Keywords:
Name View
rituximab View
bortezomib View
dexamethasone View